Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1995
09/26/1995CA2145473A1 Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals
09/26/1995CA2145472A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
09/26/1995CA2145432A1 Purine derivatives and pharmaceutically acceptable salts thereof
09/26/1995CA1337128C Propanamine derivatives
09/26/1995CA1337125C Process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it
09/26/1995CA1337124C Flavolignan derivatives, processes for the preparation thereof and pharmaceutical compositions containing these compounds
09/26/1995CA1337123C Azacyclic carboxylic acid derivatives, their preparation and use
09/26/1995CA1337122C Pharmacologically active 1,5-diaryl-3-substituted-pyrazoles and method for synthesizing the same
09/26/1995CA1337117C Use of vanilloids for the treatment of herpes simplex infections
09/25/1995CA2145469A1 Disubstituted aminoalkyloxy 3-substituted aromatic steroids used for the preparation of a drug to control fertility, especially male fertility; pharmaceutical compositions containing the same
09/24/1995CA2145257A1 Thiazolidine and oxazolidine derivatives, their preparation and their medical use
09/23/1995CA2145035A1 Polyiodinated compounds, process for preparing them and diagnostic compositions
09/23/1995CA2145027A1 Aminoalkyl benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/23/1995CA2145026A1 Aminoalkyl benzoxazolinones and benzothiazolinones; process for preparing the same and pharmaceutical compositions containing them
09/23/1995CA2143515A1 Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer
09/23/1995CA2142940A1 Method and composition having enhanced alpha-hydroxy skin permeation and retention
09/22/1995CA2144917A1 Time-released alfuzosin hydrochloride galenical forms
09/22/1995CA2144898A1 Pilocarpin production process
09/21/1995WO1995025128A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/21/1995WO1995025125A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995WO1995025110A1 Heterocyclic compounds, their preparation and use
09/21/1995WO1995025108A1 Carbapenem compounds, compositions and methods of treatment
09/21/1995WO1995025107A1 Triazole compounds and processes for the preparation thereof
09/21/1995WO1995025106A1 Oxazolidinone derivatives and pharmaceutical compositions containing them
09/21/1995WO1995025104A1 Novel heterocyclic ethanolamine derivatives with beta-adrenoreceptor agonistic activity
09/21/1995WO1995025102A1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
09/21/1995WO1995025093A1 Acridone-derived bisintercalators as chemotherapeutic agents
09/21/1995WO1995025092A1 Inhibitors of farnesyl-protein transferase
09/21/1995WO1995025091A2 Nipecotic acid derivatives as antithrombic compounds
09/21/1995WO1995025087A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/21/1995WO1995025086A1 Isoprenyl transferase inhibitors
09/21/1995WO1995024930A1 Use of green porphyrins in ocular diagnosis and therapy
09/21/1995WO1995024921A1 A medical use of matrix metalloproteinase inhibitors for inhibiting tissue contraction
09/21/1995WO1995024914A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995WO1995024910A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995WO1995024909A1 Osteoporosis preventing or treating agent
09/21/1995WO1995024908A1 Use of nitric oxide-releasing polymers to treat restenosis and related disorders
09/21/1995WO1995024906A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995WO1995024905A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments
09/21/1995WO1995024903A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
09/21/1995WO1995024902A1 Ocular tension depressant
09/21/1995WO1995024901A1 Treatment of diabetic nephropathy with valsartan
09/21/1995WO1995024900A1 Carbanilide anticoccidials
09/21/1995WO1995024899A1 Inhibition of cataracts and other disorders
09/21/1995WO1995024898A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995WO1995024897A1 Anti-viral and anti-cancer agents
09/21/1995WO1995024896A2 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
09/21/1995WO1995024895A1 Uses of perillyl alcohol and perillic acid methyl ester
09/21/1995WO1995024894A2 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
09/21/1995WO1995024892A1 Aerosol drug formulations containing vitamin e
09/21/1995WO1995024891A1 Topical thalidomide compositions for surface or mucosal wounds, ulcerations, and lesions
09/21/1995WO1995024890A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995WO1995024888A1 Methods for phototherapeutic treatment of proliferative skin diseases
09/21/1995WO1995024829A1 Topical composition for burn relief and method of use
09/21/1995WO1995022974A3 Film coated tablet of paracetamol and domperidone
09/21/1995WO1995022959A3 Sunscreen compositions
09/21/1995WO1995021612A3 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
09/21/1995WO1995020960A3 Dna damaging agents in combination with tyrosine kinase inhibitors
09/21/1995WO1995018826A3 Purified primate ctla-8 antigens and related reagents
09/21/1995DE4410637C1 Injizierbare Lösungen von Dirithromycin Injectable solutions of dirithromycin
09/21/1995DE4409357A1 Verwendung von Dimeticon zur Behandlung von Helicobacter Pylori-assoziierten Erkrankungen Use of dimethicone for the treatment of Helicobacter pylori associated diseases
09/21/1995DE4409072A1 Filling for sticking plasters having a dermatological curative effect
09/21/1995DE4408497A1 New bi:phenyl-methyl-benzimidazole derivs.
09/21/1995DE3490636C2 New double-bond isomer of 1-alpha, 25-di:hydroxy:vitamin=D-2
09/21/1995CA2185817A1 Anti-viral and anti-cancer agents
09/21/1995CA2185690A1 Method for making chewable tablets based on troxerutine, calcium carbonate, calcium phosphate, arginine aspartate, arginine glutamate, amoxicillin, a combination of calcium carbonate and magnesium carbonate, and a combination of aluminium hydroxide and magnesium hydroxide
09/21/1995CA2185675A1 Use of antagonists of egf or tgf-alpha for the treatment and prophylaxis of acne
09/21/1995CA2185670A1 Heterocyclic compounds, their preparation and use
09/21/1995CA2185663A1 Delipidated purified polysaccharide compound d25 preparation, and injectable composition comprising same
09/21/1995CA2185553A1 Inhibitors of farnesyl-protein transferase
09/21/1995CA2185458A1 Carbapenem compounds, compositions and methods of treatment
09/21/1995CA2185448A1 Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
09/21/1995CA2185441A1 Isoprenyl transferase inhibitors
09/21/1995CA2185440A1 Methods for phototherapeutic treatment of proliferative skin diseases
09/21/1995CA2185425A1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
09/21/1995CA2185341A1 Dna encoding cai resistance proteins and uses thereof
09/21/1995CA2185326A1 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
09/21/1995CA2184921A1 Carbanilide anticoccidials
09/21/1995CA2184753A1 Complexes of nitric oxide with cardiovascular amines as dual acting cardiovascular agents
09/21/1995CA2184712A1 Treatment of diabetic nephropathy with valsartan
09/21/1995CA2184352A1 Immunotherapy of cancer with allogeneic lymphocytes
09/21/1995CA2183557A1 Aerosol drug formulations containing vitamin e
09/21/1995CA2163027A1 Nipecotic acid derivatives as antithrombic compounds
09/21/1995CA2162916A1 Cyclopropylacetonitrile derivatives, preparation thereof and use thereof as drugs
09/20/1995EP0672686A1 Ganglioside gm3 derivative having fluorinated ceramide moiety
09/20/1995EP0672670A1 Process for the preparation of clavulanic acid
09/20/1995EP0672669A1 Process for the preparation of clavulanic acid
09/20/1995EP0672666A2 Imidazodiazepins
09/20/1995EP0672662A1 Quinoxaline derivative used in the treatment of tumours
09/20/1995EP0672660A2 Substituted cyclohexanol-esters, their use to treat illnesses and pharmaceutical preparations
09/20/1995EP0672658A1 Antithrombotic agents
09/20/1995EP0672422A1 Antiinflammatory and analgesic transdermal gel
09/20/1995EP0672418A2 Use of adenosine monophosphate deaminase inhibitor for increasing extracellular adenosine
09/20/1995EP0672417A1 Reduction of elevated intraocular pressure
09/20/1995EP0672416A1 Pharmaceutical composition comprising diamorphine
09/20/1995EP0672415A1 Organopathy preventing, curing or ameliorating agent
09/20/1995EP0672414A2 Method for stabilizing pranoprofen and stable liquid preparation of pranoprofen
09/20/1995EP0672413A1 Novel use of (+)-2-nitroxyethyl apovincaminate
09/20/1995EP0672412A2 Use of 3,4-diphenyl chromans for the manufacture of a medicament for lowering cholesterol levels
09/20/1995EP0672411A1 Use of 2-methylamino-2-phenylcyclohexanon for the treatment of infections and as immunomodulator
1 ... 6982 6983 6984 6985 6986 6987 6988 6989 6990 6991 6992 6993 6994 6995 6996 6997 6998 6999 7000 7001 7002 ... 7860